Glucokinase regulator - Hua Medicine
Latest Information Update: 06 May 2024
At a glance
- Originator Hua Medicine
- Class Antihypoglycaemics
- Mechanism of Action Glucokinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Congenital hyperinsulinism
Most Recent Events
- 17 Apr 2024 Preclinical trials in Congenital-hyperinsulinism in China (unspecified route) (Hua Medicine pipeline, April 2024)